Multiple sclerosismedications are prescribed to treat multiple sclerosis(MS), an autoimmune disorder that affects the central nervous system (CNS). A large array of medications and therapies are used tomanage multiple sclerosis, which can affect a wide spectrum of neurological functions and cause disab...
Earn CME credits quickly and conveniently with this collection of free Multiple Sclerosis CME activities.
Consortium of Multiple Sclerosis Centers (CMSC) 2024 Annual MeetingMedscape Email Alerts Receive email with curated articles from the Multiple Sclerosis Center of Excellence Find Us On About About Medscape Privacy Policy Editorial Policy Cookies Terms of Use Advertising Policy Help Center Membership Be...
Multiple Sclerosis: Diagnosis, Medical Management, and Rehabilitation edited by Jack S. Burks and Kenneth P. Johnson. Demos Medical Publishing, New York, 2000. 624 pp., ISBN 18799 US $175.00, International $210.00No abstract is available for this article....
多发性硬化(multiple sclerosis ,MS)是一种以中枢神经系统(CNS)白质炎性脱髓鞘为主的自身免疫性疾病。本病病变以多灶损害、病灶不定、临床表现多样、病程中常有自然缓解与复发等为特征。发时多有视力减退,下肢痿软无力,肌肤感觉异常,或肢体疼痛,或突发眩晕,听力下降,或言语不清、吞咽困难,动作笨拙,行走不稳,或情...
Multiple sclerosis (MS) is a neuro-inflammatory and neurodegenerative disease that is most prevalent in Northern Europe. Although it is known that inherited risk for MS is located within or in close proximity to immune-related genes, it is unknown when, where and how this genetic risk originated...
Multiple sclerosis (MS) is a neuro-inflammatory and neurodegenerative disease that is most prevalent in Northern Europe. Although it is known that inherited risk for MS is located within or in close proximity to immune-related genes, it is unknown when, where and how this genetic risk originated...
HLA-DRB1* allele-associated genetic susceptibility and protection against multiple sclerosis in Brazilian patients Mol. Med. Rep., 2 (2009), pp. 993-998 View in ScopusGoogle Scholar [21] S.V. Ramagopalan, A.P. Morris, D.A. Dyment, B.M. Herrera, G.C. DeLuca, et al. The inheritanc...
Association of chronic active multiple sclerosis lesions with disability in vivo. JAMA Neurol. 76, 1474–1483 (2019). Article PubMed PubMed Central Google Scholar Elliott, C., et al. Chronic white matter lesion activity predicts clinical progression in primary progressive multiple sclerosis. Brain...
3. Who gets MS? Multiple Sclerosis Association of America Web site. www.msassociation.org/about_multiple_sclerosis/whogets/. Accessed October 14, 2011. 4. Courtney AM, Treadaway K, Remington G, Frohman E. Multiple sclerosis.Med Clin North Am. 2009;93(2):451-476. ...